{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:12:28Z","timestamp":1790766748058,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,4,30]],"date-time":"2008-04-30T00:00:00Z","timestamp":1209513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s10549-008-0036-z","type":"journal-article","created":{"date-parts":[[2008,4,29]],"date-time":"2008-04-29T11:37:13Z","timestamp":1209469033000},"page":"457-462","source":"Crossref","is-referenced-by-count":72,"title":["The prevalence of PALB2 germline mutations in BRCA1\/BRCA2 negative Chinese women with early onset breast cancer or affected relatives"],"prefix":"10.1007","volume":"114","author":[{"given":"A-Yong","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Liang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Li","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Xi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen-Hong","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Wei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Song","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Min","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Tao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Zhou","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,4,30]]},"reference":[{"key":"36_CR1","doi-asserted-by":"crossref","unstructured":"Li WF, Hu Z, Rao NY et al. (2007) The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat doi: 10.1007\/s10549-007-9708-3 (in press)","DOI":"10.1007\/s10549-007-9708-3"},{"key":"36_CR2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.molcel.2006.05.022","volume":"22","author":"B Xia","year":"2007","unstructured":"Xia B, Sheng Q, Nakanishi K, Ohashi A et al (2007) Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell 22:719\u2013729","journal-title":"Mol Cell"},{"issue":"2","key":"36_CR3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1470-2045(07)70025-6","volume":"8","author":"S Simpson","year":"2007","unstructured":"Simpson S (2007) PALB2-new breast-cancer susceptibility gene. Lancet Oncol 8(2):105","journal-title":"Lancet Oncol"},{"key":"36_CR4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ng1942","volume":"39","author":"B Xia","year":"2007","unstructured":"Xia B, Dorsman JC, Ameziane N et al (2007) Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 39:159\u2013161","journal-title":"Nat Genet"},{"key":"36_CR5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ng1947","volume":"39","author":"S Reid","year":"2007","unstructured":"Reid S, Schindler D, Hanenberg H et al (2007) Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 39:162\u2013164","journal-title":"Nat Genet"},{"key":"36_CR6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/sj.ejhg.5201860","volume":"15","author":"NG Howlett","year":"2007","unstructured":"Howlett NG (2007) Fanconi anemia: Fanconi anemia, breast and embryonal cancer risk revisited. Eur J Hum Genet 15:715\u20137","journal-title":"Eur J Hum Genet"},{"key":"36_CR7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ccr.2007.01.010","volume":"11","author":"T Walsh","year":"2007","unstructured":"Walsh T, King MC (2007) Ten genes for inherited breast cancer. Cancer Cell 11:103\u2013105","journal-title":"Cancer Cell"},{"key":"36_CR8","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/jnci\/djj500","volume":"98","author":"K Offit","year":"2006","unstructured":"Offit K (2006) BRCA mutation frequency and penetrance: new data, old debate. J Natl Cancer Inst 98:1675\u20131677","journal-title":"J Natl Cancer Inst"},{"key":"36_CR9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng1959","volume":"39","author":"N Rahman","year":"2007","unstructured":"Rahman N, Seal S, Thompson D et al (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39:165\u2013167","journal-title":"Nat Genet"},{"key":"36_CR10","unstructured":"Garc\u00eda MJ, Fern\u00e1ndez V, Osorio A et al. (2008) Analysis of FANCB and FANCN\/PALB2 Fanconi Anemia genes in BRCA1\/2-negative Spanish breast cancer families. Breast Cancer Res Treat doi: 10.1007\/s10549 \u2013008-9945-0 (in press)"},{"key":"36_CR11","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/bcr1828","volume":"9","author":"WD Foulkes","year":"2007","unstructured":"Foulkes WD, Ghadirian P, Akbari MR et al (2007) Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French\u2013Canadian women. Breast Cancer Res 9:R83","journal-title":"Breast Cancer Res"},{"key":"36_CR12","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature05609","volume":"446","author":"H Erkko","year":"2007","unstructured":"Erkko H, Xia B, Nikkil\u00e4 J et al (2007) A recurrent mutation in PALB2 in Finnish cancer families. Nature 446:316\u2013319","journal-title":"Nature"},{"key":"36_CR13","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1073\/pnas.0701724104","volume":"104","author":"M Tischkowitz","year":"2007","unstructured":"Tischkowitz M, Xia B, Sabbaghian N et al (2007) Analysis of PALB2\/FANCN-associated breast cancer families. Proc Natl Acad Sci USA 104:6788\u20136793","journal-title":"Proc Natl Acad Sci USA"},{"key":"36_CR14","first-page":"104","volume":"18","author":"K Offit","year":"2000","unstructured":"Offit K (2000) Are BRCA1- and BRCA2-associated breast cancers different? J Clin Oncol 18:104\u2013106","journal-title":"J Clin Oncol"},{"key":"36_CR15","first-page":"107","volume":"18","author":"KA Phillips","year":"2000","unstructured":"Phillips KA (2000) Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers. J Clin Oncol 18:107\u2013112","journal-title":"J Clin Oncol"},{"key":"36_CR16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/00313020220147113","volume":"34","author":"JE Armes","year":"2002","unstructured":"Armes JE, Venter DJ (2002) The pathology of inherited breast cancer. Pathology 34:309\u2013314","journal-title":"Pathology"},{"key":"36_CR17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s004390100500","volume":"108","author":"B Klein","year":"2001","unstructured":"Klein B, Weirich G, Brauch H (2001) DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: usefulness and limitations. Hum Genet 108:376\u2013384","journal-title":"Hum Genet"},{"key":"36_CR18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/humu.1130","volume":"17","author":"W Xiao","year":"2001","unstructured":"Xiao W, Oefner PJ (2001) Denaturing high-performance liquid chromatography: a review. Hum Mutat 17:439\u2013474","journal-title":"Hum Mutat"},{"key":"36_CR19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00432-006-0105-9","volume":"32","author":"CG Song","year":"2006","unstructured":"Song CG, Hu Z, Wu J et al (2006) The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer. J Cancer Res Clin Oncol 32:617\u2013626","journal-title":"J Cancer Res Clin Oncol"},{"key":"36_CR20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/humu.9156","volume":"22","author":"Z Hu","year":"2003","unstructured":"Hu Z, Wu J, Liu CH et al (2003) The analysis of BRCA1 mutations in eastern Chinese patients with early onset breast cancer and affected relatives. Hum Mutat 22:104","journal-title":"Hum Mutat"},{"key":"36_CR21","unstructured":"NCBI [ http:\/\/www.ncbi.nlm.nih.gov\/ ]"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-008-0036-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-008-0036-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-008-0036-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:28:58Z","timestamp":1559233738000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-008-0036-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,30]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["36"],"URL":"https:\/\/doi.org\/10.1007\/s10549-008-0036-z","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,30]]}}}